Tirzepatide
Tirzepatide is an FDA-approved medication that targets two gut hormones at once to support weight loss and blood sugar control.
Quick facts
FDA-approved (Type 2 Diabetes / Weight Management)
Phase 3 Complete
What is Tirzepatide?
Tirzepatide works by acting like two natural hormones in your gut, GIP and GLP-1. Your body releases these hormones after you eat to signal that you are full. By targeting both pathways at the same time, tirzepatide slows down digestion, lowers appetite, and helps the body handle blood sugar better. This dual action is why it is used for chronic weight management and type 2 diabetes.
Common Uses
Tirzepatide is FDA-approved for chronic weight management, with Phase 3 trials demonstrating an average body weight reduction of 20.9% over 72 weeks.
Tirzepatide is FDA-approved to manage type 2 diabetes, with clinical trials showing significant improvements in glycemic control.
In clinical trials, tirzepatide was associated with an 8% relative reduction in major adverse cardiovascular events.
Research suggests tirzepatide acts on hormone receptors in the brain and gut to help lower appetite and reduce food noise.
Studies & Clinical Research
Tirzepatide is the first-in-class dual GIP and GLP-1 receptor agonist, delivering unprecedented results in weight loss and
Tirzepatide acts like two natural gut hormones, GLP-1 and GIP, to tell your body to reduce appetite and slow digestion. Because tirzepatide targets both pathways at the same time, it helps improve blood sugar control and supports weight loss.
Tirzepatide is FDA-approved and was generally well-tolerated in Phase 3 clinical trials. The most common side effects are mild stomach issues like nausea and diarrhea, which usually happen when the dose is increased. A licensed provider can help decide if tirzepatide is right for you.
In clinical trials, meaningful weight loss with tirzepatide was observed within the first 4 to 8 weeks, with the most significant results over 12 to 72 weeks. Individual results will vary based on diet and lifestyle.
Yes. Tirzepatide is a prescription-only, FDA-approved medication. A licensed healthcare provider must review your health history before prescribing tirzepatide.
Have a question you don’t see answered?
Ready to take the next step?
Find a verified peptide therapy provider or list your practice and connect with patients actively seeking trusted care.